Financhill
Back

BeiGene Quote, Financials, Valuation and Earnings

BeiGene Price Quote

$207.51
+3.30 (+1.62%)
(Updated: November 4, 2024 at 5:55 PM ET)

BeiGene Key Stats

Sell
35
BeiGene (BGNE) is a Sell

Day range:
$202.90 - $209.05
52-week range:
$126.97 - $248.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.92
P/B ratio:
6.44%

Volume:
245.6K
Avg. volume:
349.5K
1-year change:
12.64%
Market cap:
$21.7B
Revenue:
$2.5B
EPS:
$-5.2

How Much Does BeiGene Make?

  • How Much Are BeiGene's Sales Annually?
    BGNE Revenues are $2.5B
  • How Much Profit Does BeiGene's Make A Year?
    BGNE net income is -$881.7M

Is BeiGene Growing As A Company?

  • What Is BeiGene's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.56%
  • What Is BeiGene's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BeiGene Stock Price Performance

  • Did BeiGene Stock Go Up Last Month?
    BeiGene share price went down by -11.59% last month
  • Did BGNE's Share Price Rise Over The Last Year?
    BGNE share price rose by 12.64% over the past 1 year

What Is BeiGene 52-Week High & Low?

  • What Is BeiGene’s 52-Week High Share Price?
    BeiGene has traded as high as $248.16 over the past 52 weeks
  • What Is BeiGene’s 52-Week Low Share Price?
    BeiGene has traded as low as $126.97 over the past 52 weeks

BeiGene Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BeiGene?

  • How Much Debt Does BeiGene Have?
    Total long term debt quarterly is $1B
  • How Much Cash Does BeiGene Have?
    Cash and short term investments quarterly total is $2.6B
  • What Is BeiGene’s Book Value Per Share?
    Book value per share is 31.81

Is BeiGene Cash Flow Positive?

  • What Is BGNE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$703.9M
  • What Is BeiGene’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $455.6M
  • What Is BeiGene’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$569.7M

BeiGene Return On Invested Capital

  • Is Management Doing A Good Job?
    BGNE return on invested capital is -11.94%
  • What Is BeiGene Return On Assets?
    ROA measures how assets are converting to revenues and is -9.21%
  • What Is BGNE Return On Equity?
    ROE is a measure of profitability and is -14.69%

BeiGene Earnings Date & Stock Price

  • What Is BeiGene's Stock Price Today?
    A single share of BGNE can be purchased today for 204.21
  • What Is BeiGene’s Stock Symbol?
    BeiGene trades on the nasdaq under the ticker symbol: BGNE
  • When Is BeiGene’s Next Earnings Date?
    The next quarterly earnings date for BeiGene is scheduled on November 8, 2024
  • When Is BGNE's next ex-dividend date?
    BeiGene's next ex-dividend date is November 5, 2024
  • How To Buy BeiGene Stock?
    You can buy BeiGene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

BeiGene Competitors

  • Who Are BeiGene's Competitors?
    Below is a list of companies who compete with BeiGene or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Bristol-Myers Squibb Co (BMY)
    • LumiraDx Ltd (LMDXF)
    • Merck & Co Inc (MRK)
    • Theravance Biopharma Inc (TBPH)

BeiGene Dividend Yield

  • What Is BGNE Dividend Yield?
    BeiGene’s dividend yield currently is 0%
  • What Is BeiGene’s Payout Ratio?
    BeiGene’s payout ratio is 0%
  • When Did BeiGene Last Pay A Dividend?
    The latest dividend pay date is November 5, 2024
  • What Is BeiGene’s Dividend Per Share?
    BeiGene pays a dividend of $0.00 per share

BeiGene Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 46.33%
Revenue: 56.09% 14.83%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 276.99
Upside from Last Price: 35.64%

Major Shareholders

  • How many BGNE shares are owned by institutional investors?
    66.2M BGNE shares are owned by institutional investors
  • How many BGNE shares are owned by insiders?
    10.1M BGNE shares are owned by insiders